CHINA PHARMA HOLDINGS, INC. Finite-Lived Intangible Assets, Net
CHINA PHARMA HOLDINGS, INC. (CPHI) had Finite-Lived Intangible Assets, Net of $37.98 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-14
- 2026-06-30: Finite-Lived Intangible Assets, Net $37.98M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $38.33M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $23.74M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $8.45M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $37.98M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $38.33M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $23.74M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.45M 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $6.44M 10-K · filed 2026-04-01 | $6.70M 10-K · filed 2025-03-31 |
| 2024-09-30 | $4.36M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.39M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $3.26M 10-Q · filed 2024-11-13 | |
| 2023-09-30 | $1.64M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.68M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.83M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.81M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $106.79K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $122.13K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $138.80K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $147.84K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $154.82K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $164.94K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $171.51K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $182.15K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $183.54K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $185.24K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $193.77K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $205.61K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $211.49K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $226.53K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $250.27K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $266.44K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $289.05K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $327.76K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $379.33K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $398.86K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $429.05K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $453.38K 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $534.68K 10-K · filed 2018-04-02 | |
| 2013-09-30 | $2.07M 10-Q · filed 2013-11-14 | |
| 2012-12-31 | $2.41M 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |